Tex. Health & Safety Code Section 1003.051
Definitions


In this subchapter:

(1)

“Investigational stem cell treatment” means an adult stem cell treatment that:

(A)

is under investigation in a clinical trial and being administered to human participants in that trial; and

(B)

has not yet been approved for general use by the United States Food and Drug Administration.

(2)

“Severe chronic disease” means a condition, injury, or illness that:

(A)

may be treated;

(B)

is never cured or eliminated; and

(C)

entails significant functional impairment or severe pain.

(3)

“Terminal illness” means an advanced stage of a disease with an unfavorable prognosis that, without life-sustaining procedures, will soon result in death or a state of permanent unconsciousness from which recovery is unlikely.
Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.

Source: Section 1003.051 — Definitions, https://statutes.­capitol.­texas.­gov/Docs/HS/htm/HS.­1003.­htm#1003.­051 (accessed Apr. 29, 2024).

Accessed:
Apr. 29, 2024

§ 1003.051’s source at texas​.gov